BC Week In Review | Oct 15, 2001
Clinical News

BioAstin natural astaxanthin regulatory update

CYAN received notice of allowance for a U.S. patent covering a method of retarding and ameliorating canker sores based on CYAN's Bioastin natural astaxanthin antioxidant. Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin natural astaxanthin...
BC Week In Review | Sep 10, 2001
Clinical News

BioAstin astaxanthin: Marketed as a dietary supplement

Preliminary results from a double-blind, placebo-controlled U.S. study showed that BioAstin did not significantly reduce DOMS compared to placebo. However CYAN said that treatment with BioAstin did reduce knee soreness as measured 48 hours after...
BC Week In Review | Jul 2, 2001
Clinical News

Bioastin astaxanthin: Started trial

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: Bioastin astaxanthin   Business: Nutraceuticals, Cardiovascular   Therapeutic category: Antioxidant, Nutraceutical   Target: Free radicals   Description: Microalgae-derived antioxidant delivered orally   Indication: Treat dyslipidemia   End point:...
BC Week In Review | May 7, 2001
Clinical News

BioAstin astaxanthin regulatory update

CYAN received notice of allowance for a U.S. patent covering the use of BioAstin to delay and improve carpal tunnel syndrome and tenosynovitis. Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin astaxanthin   Business: Nutraceuticals,...
BC Week In Review | Apr 16, 2001
Clinical News

BioAstin astaxanthin: Began U.S. study

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin astaxanthin   Business: Nutraceuticals, Dermatology   Therapeutic category: Antioxidant, Nutraceutical   Target: Free radicals   Description: Natural antioxidant pigment delivered orally   Indication: Prevent sunburn   End...
BC Week In Review | Mar 26, 2001
Clinical News

BioAstin astaxanthin: Began second study

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin astaxanthin   Business: Nutraceuticals   Therapeutic category: Antioxidant, Nutraceutical   Target: Free radicals   Description: Natural antioxidant pigment   Indication: Reduce delayed onset muscle soreness (DOMS)  ...
BC Week In Review | Mar 12, 2001
Company News

Aquasearch, Cyanotech biomanufacturing news

The companies settled litigation under which AQSE alleged infringement of its U.S. Patent No. 5,541,056 covering the cultivation of microalgae in a closed system bioreactor, and claimed CYAN breached the companies' 1994 agreement and misappropriated...
BC Week In Review | Feb 5, 2001
Clinical News

BioAstin astaxanthin: Began Clinical Testing

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin astaxanthin   Business: Nutraceuticals   Therapeutic category: Antioxidant, Nutraceutical   Target: Free radicals   Description: Natural pigment antioxidant   Indication: Reduce delayed onset muscle soreness (DOMS)  ...
BC Week In Review | Jan 2, 2001
Company News

Cyanotech board of directors update

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Business: Nutraceuticals, Supply/Service   Appointed: David Rosenthal, EVP and CFO at intelliReady Inc.  ...
BC Week In Review | Nov 6, 2000
Company News

Cyanotech, Kyowa Hakko Kogyo Co. Ltd. deal

Kyowa Hakko’s Kyowa Engineering Co. unit will distribute CYAN’s BioAstin astaxanthin antioxidant product in Japan. The three-year agreement calls for a payment to CYAN and an additional payment prior to CYAN starting two clinical trials...
Items per page:
1 - 10 of 27
BC Week In Review | Oct 15, 2001
Clinical News

BioAstin natural astaxanthin regulatory update

CYAN received notice of allowance for a U.S. patent covering a method of retarding and ameliorating canker sores based on CYAN's Bioastin natural astaxanthin antioxidant. Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin natural astaxanthin...
BC Week In Review | Sep 10, 2001
Clinical News

BioAstin astaxanthin: Marketed as a dietary supplement

Preliminary results from a double-blind, placebo-controlled U.S. study showed that BioAstin did not significantly reduce DOMS compared to placebo. However CYAN said that treatment with BioAstin did reduce knee soreness as measured 48 hours after...
BC Week In Review | Jul 2, 2001
Clinical News

Bioastin astaxanthin: Started trial

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: Bioastin astaxanthin   Business: Nutraceuticals, Cardiovascular   Therapeutic category: Antioxidant, Nutraceutical   Target: Free radicals   Description: Microalgae-derived antioxidant delivered orally   Indication: Treat dyslipidemia   End point:...
BC Week In Review | May 7, 2001
Clinical News

BioAstin astaxanthin regulatory update

CYAN received notice of allowance for a U.S. patent covering the use of BioAstin to delay and improve carpal tunnel syndrome and tenosynovitis. Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin astaxanthin   Business: Nutraceuticals,...
BC Week In Review | Apr 16, 2001
Clinical News

BioAstin astaxanthin: Began U.S. study

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin astaxanthin   Business: Nutraceuticals, Dermatology   Therapeutic category: Antioxidant, Nutraceutical   Target: Free radicals   Description: Natural antioxidant pigment delivered orally   Indication: Prevent sunburn   End...
BC Week In Review | Mar 26, 2001
Clinical News

BioAstin astaxanthin: Began second study

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin astaxanthin   Business: Nutraceuticals   Therapeutic category: Antioxidant, Nutraceutical   Target: Free radicals   Description: Natural antioxidant pigment   Indication: Reduce delayed onset muscle soreness (DOMS)  ...
BC Week In Review | Mar 12, 2001
Company News

Aquasearch, Cyanotech biomanufacturing news

The companies settled litigation under which AQSE alleged infringement of its U.S. Patent No. 5,541,056 covering the cultivation of microalgae in a closed system bioreactor, and claimed CYAN breached the companies' 1994 agreement and misappropriated...
BC Week In Review | Feb 5, 2001
Clinical News

BioAstin astaxanthin: Began Clinical Testing

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Product: BioAstin astaxanthin   Business: Nutraceuticals   Therapeutic category: Antioxidant, Nutraceutical   Target: Free radicals   Description: Natural pigment antioxidant   Indication: Reduce delayed onset muscle soreness (DOMS)  ...
BC Week In Review | Jan 2, 2001
Company News

Cyanotech board of directors update

Cyanotech Corp. (CYAN), Kailua-Kona, Hawaii   Business: Nutraceuticals, Supply/Service   Appointed: David Rosenthal, EVP and CFO at intelliReady Inc.  ...
BC Week In Review | Nov 6, 2000
Company News

Cyanotech, Kyowa Hakko Kogyo Co. Ltd. deal

Kyowa Hakko’s Kyowa Engineering Co. unit will distribute CYAN’s BioAstin astaxanthin antioxidant product in Japan. The three-year agreement calls for a payment to CYAN and an additional payment prior to CYAN starting two clinical trials...
Items per page:
1 - 10 of 27